Novel Mutation of the GNE Gene Presenting Atypical Mild Clinical Feature: A Korean Case Report
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase (GNE) myopathy is caused by mutations in GNE, a key enzyme in sialic acid biosynthesis. Here, we reported a case of GNE that presented with atypical mild clinical feature and slow progression. A 48-year-old female had a complaint of left foot drop since the age of 46 years. Electromyography (EMG) and muscle biopsy from left tibialis anterior muscle were compatible with myopathy. Genetic analysis led to the identification of c.1714G>C/c.527A>T compound heterozygous mutation, which is the second most frequent mutation in Japan as far as we know. Previous research has revealed that c.1714G>C/c.527A>T compound heterozygous mutation is a mild mutation as the onset of the disease is much later than the usual age of onset of GNE myopathy and the clinical course is slowly progressive. This was the first case report in Korea of the clinicopathological characteristics of GNE myopathy with GNE (c.1714G>C/c.527A>T compound heterozygous) mutation.
Abstract
Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase (GNE) myopathy is caused by mutations in GNE, a key enzyme in sialic acid biosynthesis. Here, we reported a case of GNE that presented with atypical mild clinical feature and slow progression. A 48-year-old female had a complaint of left foot drop since the age of 46 years. Electromyography (EMG) and muscle biopsy from left tibialis anterior muscle were compatible with myopathy. Genetic analysis led to the identification of c.1714G>C/c.527A>T compound heterozygous mutation, which is the second most frequent mutation in Japan as far as we know. Previous research has revealed that c.1714G>C/c.527A>T compound heterozygous mutation is a mild mutation as the onset of the disease is much later than the usual age of onset of GNE myopathy and the clinical course is slowly progressive. This was the first case report in Korea of the clinicopathological characteristics of GNE myopathy with GNE (c.1714G>C/c.527A>T compound heterozygous) mutation.
참고문헌 (6)
- Nonaka I, "Distal myopathy with rimmed vacuoles and hereditary inclusion body myopathy", Curr Neurol Neurosci Rep, 5, pp.61~65 (2005)
- Stasche R, "A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic acid biosynthesis of rat liver. Molecular cloning and functional expression of UDP-N-acetyl-glucosamine 2-epimerase", N-acetylmannosamine kinase, 1997, pp.272, 24319~24324
- Kim BJ, "Mutation analysis of the GNE gene in Korean patients with distal myopathy with rimmed vacuoles", J Hum Genet, 51, pp.137~140 (2006)
- Udd B., "Distal myopathies: new genetic entities expand diagnostic challenge", Neuromuscul Disord, 22, pp.5~12 (2012)
- Cho A, "Mutation profile of the GNE gene in Japanese patients with distal myopathy with rimmed vacuoles (GNE myopathy)", J Neurol Neurosurg Psychiatry, 85, pp.914~917 (2014)
- Ohno K., "Mutation analysis of a large cohort of GNE myopathy reveals a diverse array of GNE mutations affecting sialic acid biosynthesis", J Neurol Neurosurg Psychiatry, 85, pp.831~ (2014)